Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials

BACKGROUND: The survival benefit of neoadjuvant therapy in resectable carcinoma esophagus has been elucidated. We performed a meta-analysis in light of new studies and long-term results of past trials. The search strategy was refined to include only “neoadjuvant” so that any bias by adjuvant treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Tarun, Pai, Esha, Singh, Rajesh, Francis, Neville J., Pandey, Manoj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085863/
https://www.ncbi.nlm.nih.gov/pubmed/32199464
http://dx.doi.org/10.1186/s12957-020-01830-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085863/
https://www.ncbi.nlm.nih.gov/pubmed/32199464
http://dx.doi.org/10.1186/s12957-020-01830-x

Ejemplares similares